TrialSafety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
Trial details
- Registry ID
- NCT05348200
- Phase
- Phase 2
Drug research
Monad 3
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Halobetasol Propionate
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade HemorrhoidsNCT05348200 | CTXR | Phase 2 | Completed | 2023-04-20Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |